Vimarsana
Biggest News Aggregation in the World

Page 5 - Impulse Dynamics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Impulse Dynamics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Impulse Dynamics Today - Breaking & Trending Today

Cleveland Clinic heart health: World's first dual cardiac device - Vimarsana News

Cleveland Clinic heart health: World's first dual cardiac device

The Cleveland Clinic says they have implanted a dual cardiac device in the first patient in the world as part of a clinical trial.

Source: wkyc.com
Cleveland Clinic has successfully implanted a dual cardiac device in the first patient in the world - Vimarsana News

Cleveland Clinic has successfully implanted a dual cardiac device in the first patient in the world

The clinical trial, sponsored by Impulse Dynamics, manufacturer of the device, will enroll 300 patients from 75 centers across the U.S. who will be followed for two years.

BERNAMA - IMPULSE DYNAMICS REACHES MILESTONE WITH 9,000TH PATIENT RECEIVING CCM THERAPY FOR HEART FAILURE - Vimarsana News

BERNAMA - IMPULSE DYNAMICS REACHES MILESTONE WITH 9,000TH PATIENT RECEIVING CCM THERAPY FOR HEART FAILURE

IMPULSE DYNAMICS REACHES MILESTONE WITH 9,000TH PATIENT RECEIVING CCM THERAPY FOR HEART FAILURE

Memphis VA first to provide life-saving procedure for heart failure patients - Vimarsana News

Memphis VA first to provide life-saving procedure for heart failure patients

The Memphis VA Medical Center is the first hospital in the Mid-South to treat heart failure patients with a new technology that gives them a second chance at life.

Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA - Vimarsana News

Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA

This randomized clinical trial examines the effect of initiation of a renin-angiotensin system inhibitor (ACE inhibitor or an angiotensin receptor blocker) on t